Pro-Dex Inc New (PDEX) is a publicly traded Healthcare sector company. As of October 29, 2026, PDEX trades at $64.99 with a market cap of $204.31M and a P/E ratio of 14.77. PDEX moved -1.65% today. Year to date, PDEX is +59.09%; over the trailing twelve months it is +100.59%. Its 52-week range spans $23.47 to $77.00. Analyst consensus is buy with an average price target of $74.00. Rallies surfaces PDEX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for PDEX combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $64.99 |
| Market Cap | $204.31M |
| P/E Ratio | 14.77 |
| EPS | $4.24 |
| Dividend Yield | 0.00% |
| 52-Week High | $77.00 |
| 52-Week Low | $23.47 |
| Volume | 40.49K |
| Avg Volume | 0 |
| Revenue (TTM) | $77.55M |
| Net Income | $13.66M |
| Gross Margin | 31.38% |
1 analysts cover PDEX: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $74.00.